Liver Cancer Trial, Recruiting (NCT06753136)

Liver Cancer Trial, Recruiting NCT06753136 Sponsor: Istituto Oncologico Veneto IRCCS Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06753136 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older
People who are able to understand the proposed treatment and who agree to take part by signing a consent form
People who have been diagnosed with cancer that has spread to internal organs (either as a primary location or spread from elsewhere), of any cancer type
People whose condition is not suitable for standard treatments aimed at curing the cancer

Who may not be able to join:

People for whom invasive medical procedures are completely ruled out for medical reasons
People who also have cancer that has spread to the brain, lungs, or bones
People with blood clotting problems that cannot be corrected
People who have an allergy to a medication called Bleomycin
People for whom Bleomycin is completely ruled out for medical reasons
People with poor lung function or a condition called pulmonary fibrosis (scarring of the lungs)
People who currently have an active lung infection
People who are pregnant, breastfeeding, or planning to become pregnant or father a child during the study period

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 049 8211693

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06753136

Sponsor: Istituto Oncologico Veneto IRCCS

Phase: Not Applicable

Status: Recruiting

Condition: Liver Cancer

Trial contact: 049 8211693

More information: https://clinicaltrials.gov/study/NCT06753136

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older
People who are able to understand the proposed treatment and who agree to take part by signing a consent form
People who have been diagnosed with cancer that has spread to internal organs (either as a primary location or spread from elsewhere), of any cancer type
People whose condition is not suitable for standard treatments aimed at curing the cancer

Who may not be able to join:

People for whom invasive medical procedures are completely ruled out for medical reasons
People who also have cancer that has spread to the brain, lungs, or bones
People with blood clotting problems that cannot be corrected
People who have an allergy to a medication called Bleomycin
People for whom Bleomycin is completely ruled out for medical reasons
People with poor lung function or a condition called pulmonary fibrosis (scarring of the lungs)
People who currently have an active lung infection
People who are pregnant, breastfeeding, or planning to become pregnant or father a child during the study period

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Istituto Oncologico Veneto IRCCS

Registry

ClinicalTrials.gov

Start date

23 July 2025

Est. completion

31 January 2030

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Primary objective and endpoint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov